All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-39599830

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39599830	A98G	RT	gag-pol	HIV Infections	D G C L	View
2	39599830	E138A	RT	gag-pol	HIV Infections	D G C L	View
3	39599830	E138G	RT	gag-pol	HIV Infections	D G C L	View
4	39599830	E138K	RT	gag-pol	HIV Infections	D G C L	View
5	39599830	E138Q	RT	gag-pol	HIV Infections	D G C L	View
6	39599830	E138R	RT	gag-pol	HIV Infections	D G C L	View
7	39599830	F227C	RT	gag-pol	HIV Infections	D G C L	View
8	39599830	F227L	RT	gag-pol	HIV Infections	D G C L	View
9	39599830	F227Y	RT	gag-pol	HIV Infections	D G C L	View
10	39599830	G190A	RT	gag-pol	HIV Infections	D G C L	View
11	39599830	G190E	RT	gag-pol	HIV Infections	D G C L	View
12	39599830	G190Q	RT	gag-pol	HIV Infections	D G C L	View
13	39599830	G190S	RT	gag-pol	HIV Infections	D G C L	View
14	39599830	H221Y	RT	gag-pol	HIV Infections	D G C L	View
15	39599830	K101E	RT	gag-pol	HIV Infections	D G C L	View
16	39599830	K101H	RT	gag-pol	HIV Infections	D G C L	View
17	39599830	K101N	RT	gag-pol	HIV Infections	D G C L	View
18	39599830	K101P	RT	gag-pol	HIV Infections	D G C L	View
19	39599830	K101T	RT	gag-pol	HIV Infections	D G C L	View
20	39599830	K103N	RT	gag-pol	HIV Infections	D G C L	View
21	39599830	K103S	RT	gag-pol	HIV Infections	D G C L	View
22	39599830	K238N	RT	gag-pol	HIV Infections	D G C L	View
23	39599830	K238T	RT	gag-pol	HIV Infections	D G C L	View
24	39599830	L100F	RT	gag-pol	HIV Infections	D G C L	View
25	39599830	L100I	RT	gag-pol	HIV Infections	D G C L	View
26	39599830	L100V	RT	gag-pol	HIV Infections	D G C L	View
27	39599830	L234I	RT	gag-pol	HIV Infections	D G C L	View
28	39599830	M230I	RT	gag-pol	HIV Infections	D G C L	View
29	39599830	M230L	RT	gag-pol	HIV Infections	D G C L	View
30	39599830	M230V	RT	gag-pol	HIV Infections	D G C L	View
31	39599830	P225H	RT	gag-pol	HIV Infections	D G C L	View
32	39599830	P225S	RT	gag-pol	HIV Infections	D G C L	View
33	39599830	T139I	RT	gag-pol	HIV Infections	D G C L	View
34	39599830	T240A	RT	gag-pol	HIV Infections	D G C L	View
35	39599830	T240I	RT	gag-pol	HIV Infections	D G C L	View
36	39599830	T240M	RT	gag-pol	HIV Infections	D G C L	View
37	39599830	T240S	RT	gag-pol	HIV Infections	D G C L	View
38	39599830	V106A	RT	gag-pol	HIV Infections	D G C L	View
39	39599830	V106I	RT	gag-pol	HIV Infections	D G C L	View
40	39599830	V108A	RT	gag-pol	HIV Infections	D G C L	View
41	39599830	V108I	RT	gag-pol	HIV Infections	D G C L	View
42	39599830	V179D	RT	gag-pol	HIV Infections	D G C L	View
43	39599830	V179E	RT	gag-pol	HIV Infections	D G C L	View
44	39599830	V179F	RT	gag-pol	HIV Infections	D G C L	View
45	39599830	V179L	RT	gag-pol	HIV Infections	D G C L	View
46	39599830	V179M	RT	gag-pol	HIV Infections	D G C L	View
47	39599830	V179T	RT	gag-pol	HIV Infections	D G C L	View
48	39599830	V90I	RT	gag-pol	HIV Infections	D G C L	View
49	39599830	Y181C	RT	gag-pol	HIV Infections	D G C L	View
50	39599830	Y181I	RT	gag-pol	HIV Infections	D G C L	View
51	39599830	Y188F	RT	gag-pol	HIV Infections	D G C L	View
52	39599830	Y188H	RT	gag-pol	HIV Infections	D G C L	View
53	39599830	Y188L	RT	gag-pol	HIV Infections	D G C L	View
54	39599830	Y232C	RT	gag-pol	HIV Infections	D G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.